BSGM: Biosig Technologies Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Biosig Technologies Inc (BSGM).
$25.68M Market Cap.
BSGM Market Cap. (MRY)
BSGM Shares Outstanding (MRY)
BSGM Assets (MRY)
Total Assets
$842.00K
Total Liabilities
$2.26M
Total Investments
$17.00K
BSGM Income (MRY)
Revenue
$40.00K
Net Income
-$10.33M
Operating Expense
$12.90M
BSGM Cash Flow (MRY)
CF Operations
-$4.76M
CF Investing
$0
CF Financing
$4.71M
BSGM Balance Sheet (MRY)
Metric | 2024 | 2023 |
|---|---|---|
Total Assets | $842,000 (-53.17%) | $1,798,000 |
Assets Current | $344,000 (-34.85%) | $528,000 |
Assets Non-Current | $498,000 (-60.79%) | $1,270,000 |
Goodwill & Intangible Assets | $269,000 (-6.60%) | $288,000 |
Shareholders Equity | -$1,544,000 (48.84%) | -$3,018,000 |
Property Plant & Equipment Net | $181,000 (-80.35%) | $921,000 |
Cash & Equivalents | $142,000 (-25.26%) | $190,000 |
Accumulated Other Comprehensive Income | $0 (0%) | $0 |
Deferred Revenue | $0 (0%) | $0 |
Total Investments | $17,000 (-85.83%) | $120,000 |
Investments Current | $13,000 (-87.38%) | $103,000 |
Investments Non-Current | $4,000 (-76.47%) | $17,000 |
Inventory | $0 (0%) | $0 |
Trade & Non-Trade Receivables | $109,000 (354.17%) | $24,000 |
Trade & Non-Trade Payables | $2,052,000 (-50.15%) | $4,116,000 |
Accumulated Retained Earnings (Deficit) | -$255,345,000 (-4.22%) | -$245,015,000 |
Tax Assets | $0 (0%) | $0 |
Tax Liabilities | $0 (0%) | $0 |
Total Debt | $102,000 (-77.43%) | $452,000 |
Debt Current | $102,000 (-70.77%) | $349,000 |
Debt Non-Current | $0 (0%) | $103,000 |
Total Liabilities | $2,264,000 (-51.68%) | $4,685,000 |
Liabilities Current | $2,264,000 (-50.59%) | $4,582,000 |
Liabilities Non-Current | $0 (0%) | $103,000 |
BSGM Income Statement (MRY)
Metric | 2024 | 2023 |
|---|---|---|
Revenues | $40,000 (122.22%) | $18,000 |
Cost of Revenue | $0 (0%) | $0 |
Selling General & Administrative Expense | $11,629,000 (-49.61%) | $23,077,000 |
Research & Development Expense | $832,000 (-83.66%) | $5,092,000 |
Operating Expenses | $12,902,000 (-54.78%) | $28,530,000 |
Interest Expense | $11,000 (0%) | $0 |
Income Tax Expense | $0 (0%) | $0 |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 |
Consolidated Income | -$10,339,000 (63.96%) | -$28,690,000 |
Net Income to Non-Controlling Interests | -$9,000 (-102.56%) | $351,000 |
Net Income | -$10,330,000 (64.43%) | -$29,041,000 |
Preferred Dividends Income Statement Impact | $183,000 (1933.33%) | $9,000 |
Net Income Common Stock | -$10,513,000 (63.81%) | -$29,050,000 |
Weighted Average Shares | $14,041,748 (91.00%) | $7,351,794 |
Weighted Average Shares Diluted | $14,041,748 (91.00%) | $7,351,794 |
Earning Before Interest & Taxes (EBIT) | -$10,319,000 (64.47%) | -$29,041,000 |
Gross Profit | $40,000 (122.22%) | $18,000 |
Operating Income | -$12,862,000 (54.89%) | -$28,512,000 |
BSGM Cash Flow Statement (MRY)
Metric | 2024 | 2023 |
|---|---|---|
Net Cash Flow from Investing | $0 (0%) | -$186,000 |
Net Cash Flow from Financing | $4,710,000 (-72.82%) | $17,332,000 |
Net Cash Flow from Operations | -$4,758,000 (72.52%) | -$17,313,000 |
Net Cash Flow / Change in Cash & Cash Equivalents | -$48,000 (71.26%) | -$167,000 |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 |
Capital Expenditure | $0 (0%) | -$186,000 |
Issuance (Repayment) of Debt Securities | $500,000 (0%) | $0 |
Issuance (Purchase) of Equity Shares | $4,210,000 (-72.59%) | $15,361,000 |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 |
Share Based Compensation | $6,957,000 (-12.80%) | $7,978,000 |
Depreciation Amortization & Accretion | $504,000 (-22.94%) | $654,000 |
BSGM Financial Metrics (MRY)
Metric | 2024 | 2023 |
|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% |
Profit Margin | -26282.50% (83.71%) | -161388.90% |
EBITDA Margin | -24537.50% (84.44%) | -157705.60% |
Return on Average Equity (ROAE) | 670.00% (-88.70%) | 5928.60% |
Return on Average Assets (ROAA) | -604.50% (26.14%) | -818.40% |
Return on Sales (ROS) | -25797.50% (84.01%) | -161338.90% |
Return on Invested Capital (ROIC) | 503.20% (-88.82%) | 4502.50% |
Dividend Yield | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -1.99 (-65.17%) | -1.2 |
Price to Sales Ratio (P/S) | 523.05 (-73.04%) | 1,940.06 |
Price to Book Ratio (P/B) | -16.63 (-19.94%) | -13.87 |
Debt to Equity Ratio (D/E) | -1.47 (5.54%) | -1.55 |
Earnings Per Share (EPS) | -0.75 (81.01%) | -3.95 |
Sales Per Share (SPS) | 0 (50.00%) | 0 |
Free Cash Flow Per Share (FCFPS) | -0.34 (85.76%) | -2.38 |
Book Value Per Share (BVPS) | -0.11 (73.24%) | -0.41 |
Tangible Assets Book Value Per Share (TABVPS) | 0.04 (-80.00%) | 0.2 |
Enterprise Value Over EBIT (EV/EBIT) | -2 (-100.00%) | -1 |
Enterprise Value Over EBITDA (EV/EBITDA) | -2.57 (-73.70%) | -1.48 |
Asset Turnover | 0.02 (360.00%) | 0.01 |
Current Ratio | 0.15 (32.17%) | 0.12 |
Dividends | $0 (0%) | $0 |
Free Cash Flow (FCF) | -$4,758,000 (72.81%) | -$17,499,000 |
Enterprise Value (EV) | $25,210,044 (-39.97%) | $41,994,093 |
Earnings Before Tax (EBT) | -$10,330,000 (64.43%) | -$29,041,000 |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$9,815,000 (65.42%) | -$28,387,000 |
Invested Capital | -$1,731,000 (38.40%) | -$2,810,000 |
Working Capital | -$1,920,000 (52.64%) | -$4,054,000 |
Tangible Asset Value | $573,000 (-62.05%) | $1,510,000 |
Market Capitalization | $25,680,044 (-38.64%) | $41,851,093 |
Average Equity | -$1,569,000 (-220.20%) | -$490,000 |
Average Assets | $1,739,000 (-51.01%) | $3,549,750 |
Invested Capital Average | -$2,050,750 (-217.95%) | -$645,000 |
Shares | 17,234,929 (95.61%) | 8,810,756 |
